Bafna Pharmaceuticals

74.05
-2.52
(-3.29%)
Market Cap
175.18 Cr
EPS
-15.52
PE Ratio
-
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
113.00
52 Week Low
69.00
PB Ratio
3.46
Debt to Equity
0.70
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,770.00
#1 4,24,682.29
34.87
#1 49,887.20
12.06
#1 9,648
13.77
59.55
5,763.00
1,52,989.54
72.74
8,184.00
0.89
1,600
#1 64.53
50.90
1,495.70
1,20,794.97
23.51
26,520.70
14.17
4,155
47.38
55.43
3,247.70
1,09,916.93
58.33
10,785.70
11.59
1,656
13.54
59.71
2,427.70
1,00,161.69
48.93
10,615.60
19.57
1,942
-16.38
56.35
1,151.45
96,083.36
#1 17.86
28,905.40
12.36
5,578
1.69
45.59
2,095.70
95,677.29
31.98
20,141.50
#1 19.94
1,936
38.82
56.82
901.90
90,752.24
19.78
19,831.50
13.82
3,831
29.92
49.00
1,176.35
68,322.60
19.09
29,559.20
17.55
3,169
-10.04
55.70
29,909.30
63,555.17
47.09
6,097.20
10.80
1,201
16.01
48.49
Growth Rate
Revenue Growth
-2.95 %
Net Income Growth
-90.21 %
Cash Flow Change
-1,816.76 %
ROE
-96.42 %
ROCE
-90.07 %
EBITDA Margin (Avg.)
-112.00 %

Quarterly Financial Results

Quarterly Financials
Jun 2018
Sept 2018
Jun 2019
Sept 2019
Revenue
12
9
7
12
Expenses
14
9
10
12
EBITDA
-2
0
-3
0
Operating Profit %
-15 %
2 %
-42 %
-3 %
Depreciation
1
1
1
1
Interest
1
1
0
0
Profit Before Tax
-4
-1
-4
-1
Tax
0
0
-2
0
Net Profit
-4
-1
-2
-1
EPS in ₹
0.00
-0.80
-0.90
-0.25

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
Total Assets
200
193
178
138
120
71
Fixed Assets
55
53
49
45
37
35
Current Assets
127
123
77
49
49
36
Capital Work in Progress
0
0
0
0
0
0
Investments
0
0
17
0
0
0
Other Assets
145
140
113
94
82
36
Total Liabilities
200
193
178
138
120
71
Current Liabilities
111
95
82
60
71
17
Non Current Liabilities
16
40
55
41
30
3
Total Equity
73
58
42
37
19
51
Reserve & Surplus
53
39
20
14
-5
-7
Share Capital
19
19
19
24
24
2

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
Net Cash Flow
0
-0
-0
0
-0
6
Investing Activities
60
-0
-5
38
15
33
Operating Activities
11
1
-1
-7
-2
-34
Financing Activities
-71
-1
6
-31
-14
7

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
91.74 %
90.39 %
90.40 %
90.42 %
90.42 %
90.12 %
90.00 %
90.02 %
90.00 %
90.00 %
88.74 %
88.43 %
88.30 %
88.30 %
88.30 %
88.30 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
6.31 %
6.23 %
6.26 %
6.10 %
5.24 %
5.50 %
5.62 %
5.61 %
5.64 %
5.64 %
6.87 %
7.66 %
7.48 %
7.37 %
7.69 %
7.66 %
Others
1.95 %
3.37 %
3.34 %
3.49 %
4.33 %
4.38 %
4.38 %
4.37 %
4.37 %
4.36 %
4.39 %
3.91 %
4.23 %
4.34 %
4.01 %
4.04 %
No of Share Holders
8,603
8,330
8,068
7,910
7,326
7,223
7,275
7,199
7,120
6,992
7,354
7,367
7,539
7,391
7,295
7,214

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %

No dividends have been distributed by the company in the past 10 years

Corporate Action

Announcements

Announcement under Regulation 30 (LODR)-Change in Directorate2 days ago
Announcement under Regulation 30 (LODR)-Resignation of Director2 days ago
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 20112 days ago
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 20112 days ago
Disclosure Under Regulation 7(2) Of SEBI (PIT) Regulations 20153 days ago
Notice of Offer for Sale of Shares by Promoter & Flooor Price8 days ago
Closure of Trading Window8 days ago
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 11, 2025
Integrated Filing (Financial)Feb 06, 2025
Unaudited Financial Results For The Quarter And Nine Months Ended 31/12/2024Feb 06, 2025
Board Meeting Outcome for Board Meeting Held On 06/02/2025Feb 06, 2025
Board Meeting Intimation for Board Meeting Scheduled On February 06 2025Jan 28, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 09, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 16, 2024
Unaudited Financial Results For The Quarter Ended 30.09.2024Nov 11, 2024
Board Meeting Outcome for Outcome Of Board Meeting Held On 11/11/2024Nov 11, 2024
Update on board meetingNov 04, 2024
Board Meeting Intimation for Board Meeting Scheduled On November 11, 2024Nov 04, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 10, 2024
Closure of Trading WindowSep 28, 2024
Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportSep 26, 2024
Announcement under Regulation 30 (LODR)-Change in DirectorateSep 25, 2024
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 25, 2024
Announcement Under Reg 30 Of SEBI (LODR) Regulations, 2015 - AwardSep 09, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 03, 2024
Notice Of 29Th Annual General Meeting Of The Company For The F.Y 2023-2024Sep 02, 2024
Reg. 34 (1) Annual Report.Sep 02, 2024
Book Closure For 29Th Annual General Meeting (AGM)Aug 30, 2024
Shareholder Meeting - 29Th AGM On September 25, 2024Aug 30, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 16, 2024
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015Aug 13, 2024
Board Meeting Outcome for Outcome Of The Board Meeting Held On 13/08/2024Aug 13, 2024
Unaudited Financial Results For The Quarter Ended 30.06.2024Aug 13, 2024
Board Meeting Intimation for Consideration And Approval Of The Unaudited Financial Results For The First Quarter Ended June 30, 2024.Aug 06, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Jul 11, 2024
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations For Temporary Disruption Of Operations.Jun 29, 2024
Closure of Trading WindowJun 25, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 31, 2024
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 30, 2024
Appointment of Company Secretary and Compliance OfficerMay 29, 2024
Board Meeting Outcome for Outcome Of The Board Meeting Held On 29/05/2024.May 29, 2024
Audited Financial Results Of The Company For The Quarter & Year Ended 31/03/2024May 29, 2024
Board Meeting Intimation for Consideration And Approval Of The Audited Financial Results Of The Company For The Quarter And Year Ended March 31, 2024May 22, 2024
Announcement Regarding Inauguration Of New Quality Control Laboratory Of CompanyApr 26, 2024
Compliance Certificate Under Regulation 7(3) Of SEBI (LODR) Regulations, 2015 For The Period Ended 31St March, 2024Apr 24, 2024
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance OfficerApr 23, 2024
Compliance Certificate Under Regulation 40(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Year Ended 31St March, 2024Apr 22, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Apr 15, 2024
Closure of Trading WindowMar 25, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 14, 2024

Technical Indicators

RSI(14)
Neutral
39.18
ATR(14)
Less Volatile
3.26
STOCH(9,6)
Neutral
28.84
STOCH RSI(14)
Oversold
10.44
MACD(12,26)
Bearish
-0.63
ADX(14)
Weak Trend
13.93
UO(9)
Bearish
50.85
ROC(12)
Downtrend And Accelerating
-8.00
WillR(14)
Neutral
-79.58